活血化瘀法治疗脊髓型颈椎病的效果评价

Evaluation of the effect of activating blood circulation and removing blood stasis on cervical spondylotic myelopathy

目的:分析用活血化瘀法治疗脊髓型颈椎病的效果。方法:从2019年4月至2020年4月期间在临沂市中医医院接受治疗的脊髓型颈椎病患者中抽选66例患者作为研究对象。将其随机分为对照组和观察组。对对照组患者进行常规的保守治疗,在此基础上为观察组患者应用活血化瘀法进行治疗。然后比较两组患者的颈椎功能、疼痛症状、血清炎症因子的水平和不良反应的发生情况。结果:1)治疗后,观察组患者日本骨科协会评估治疗评分法(JOA)的评分高于对照组患者,其数字评分法(NRS)的评分低于对照组患者,P<0.05。2)治疗后,观察组患者血清白细胞介素-1β(IL-1β)、白细胞介素-6(IL-6)及肿瘤坏死因子-α(TNF-α)的水平均低于对照组患者,P<0.05。3)在治疗期间,两组患者均未出现明显的不良反应。结论:用活血化瘀法治疗脊髓型颈椎病的临床疗效显著,且安全性较高。

Objective:To analyze the effect of promoting blood circulation and removing blood stasis in the treatment of cervical spondylotic myelopathy.Methods:Sixty-six patients with cervical spondylotic myelopathy who received treatment in Linyi Hospital of Traditional Chinese Medicine from April 2019 to April 2020 were selected as the study subjects.They were randomly divided into control group and observation group.The control group was treated with conventional conservative treatment,and the observation group was treated with the method of promoting blood circulation and removing stasis.Cervical spine function,pain symptoms,serum inflammatory cytokines levels and adverse reactions were compared between the two groups.Results:1)After treatment,the JOA score of the observation group was higher than that of the control group,while the NRS score was lower than that of the control group,P<0.05.2)After treatment,the serum levels of interleukin-1β(IL-1β),interleukin-6(IL-6)and tumor necrosis factor-α(TNF-α)in observation group were lower than those in control group,P<0.05.3)During treatment,no obvious adverse reactions occurred in 2 groups.Conclusion:The treatment of cervical spondylotic myelopathy by activating blood circulation and removing blood stasis has significant clinical efficacy and high safety.